SCHEMBL1720149

SCHEMBL1720149

Cl[Ru]C1=CC=CC1.c1ccc(P(CP(c2ccccc2)c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1006483 0.85 CYP3A4 (0.43)
SCHEMBL3007784 0.74
SCHEMBL29028258 0.74 CYP3A4 (0.41)
SCHEMBL3006863 0.70
Carbon Monoxide SCHEMBL1982955 0.70
SCHEMBL114543 0.70 CYP3A4 (0.50)
SCHEMBL3007015 0.68 CYP3A4 (0.43)
SCHEMBL5388290 0.67 CYP3A4 (0.47)
SCHEMBL8539745 0.67 CYP3A4 (0.47)
SCHEMBL9661126 0.67 CYP3A4 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2057127-B1 HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS SCHERING CORP (US) 2012-01-11 EP disclosed
US-7998961-B2 For treating conditions associated with UDP-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) SCHERING CORPORATION (US) 2011-08-16 US disclosed
EP-2057127-A1 HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS SCHERING CORPORATION (US) 2009-05-13 EP disclosed
WO-2008027466-A1 HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS SCHERING CORPORATION (US) 2008-03-06 WO disclosed